Emergent Biosolutions Inc. P/E ratio

P/E ratio of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/E ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its earnings per share. A low P/E ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. P/E ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current P/E ratio of Emergent Biosolutions Inc. is 0.0 (as of December 31, 2022)
  • P/E ratio for the quarter ending June 30, 2023 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly P/E ratio decreased by -100.0%
  • Annual P/E ratio for 2022 was 0.0 (a -100.0% decrease from previous year)
  • Annual P/E ratio for 2021 was 10.04 (a -35.24% decrease from previous year)
  • Annual P/E ratio for 2020 was 15.5 (a -69.54% decrease from previous year)
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/E ratio of Emergent Biosolutions Inc.

Most recent P/E ratioof EBS including historical data for past 10 years.

Interactive Chart of P/E ratio of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. P/E ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 0.0 0.0 – – –
2022 0.0 25.6 17.94 13.92 0.0
2021 10.04 11.64 11.13 12.68 10.04
2020 15.5 32.49 24.18 43.5 15.5
2019 50.9 653.5 0.0 59.8 50.9
2018 47.42 31.16 20.99 31.87 47.42
2017 24.6 20.86 20.07 22.17 24.6
2016 28.9 26.28 17.25 16.01 28.9
2015 25.01 18.38 27.92 30.6 25.01
2014 28.36 36.74 60.7 47.68 28.36
2013 26.73 21.4 21.21 21.87 26.73
2012 24.68 14.47 – – 24.68

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com